相关实验视频

Updated: Jul 6, 2025

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

ALS - Motor Neuron Disease: Mechanism and Development of New Therapies

Published on: July 29, 2007

遗传性性:对病原和管理的新见解

Wireko Andrew Awuah¹, Joecelyn Kirani Tan², Anastasiia D Shkodina³

¹Sumy State University, Sumy, Ukraine.

SAGE open medicine

|January 1, 2024

概括

遗传性性 (HSP) 是一种神经退行性疾病,由于神经纤维退化导致下肢硬. 本综述探讨了代谢机制和基因相互作用,以指导针对HSP的向分子疗法的开发.

科学领域:

神经遗传学神经遗传学
分子医学是分子医学.
细胞生物学细胞生物学

背景情况:

遗传性性 (HSP) 是一种遗传多样性的神经退行性疾病.
它的特点是下肢上皮质脊髓系神经纤维的逐渐退化.
由于肌肉硬和移动性问题,HSP会影响生活质量,目前尚无治疗方法.

研究的目的:

审查 HSP 病理生理学的代谢机制.
从网络研究中强调涉及HSP的各种基因的相互作用.
为开发针对HSP的向分子疗法提供信息.

主要方法:

文献综述,重点关注HSP的代谢途径和遗传关联.
分析与HSP相关的细胞和代谢过程,包括线粒体功能障碍,内分泌网膜重塑,自,髓化和脂质代谢.
检查与HSP进展和严重程度相关的基因位置和网络相互作用.

主要成果:

高血压病理生理学涉及遗传因素和细胞/代谢功能障碍之间的复杂相互作用.
关键受影响的过程包括线粒体功能,ER膜动力学,自,髓化,脂质代谢和内体体贩运.
遗传位置和相关基因显著影响疾病进展和症状严重程度.

结论:

了解HSP复杂的代谢机制和基因网络对于治疗开发至关重要.
针对这些生化过程的向分子疗法有望改善HSP治疗策略.
对基因代谢相互作用的进一步研究可以指导临床实践并改善患者的治疗结果.

关键词:

遗传性性增生症遗传性性增生症遗传学遗传学遗传学是一个代谢过程中的代谢.神经退行症的神经退行症

更多相关视频

Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia

Analyzing Mitochondrial Transport and Morphology in Human Induced Pluripotent Stem Cell-Derived Neurons in Hereditary Spastic Paraplegia

Published on: February 9, 2020

Conversion of Human Induced Pluripotent Stem Cells iPSCs into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors

Conversion of Human Induced Pluripotent Stem Cells iPSCs into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors

Published on: May 1, 2019

相关概念视频

Parkinson's Disease: Overview

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...